Arachidonic acid and other polyunsaturated fatty acids (PUFAs) are oxidatively metabolized by cyclooxygenase, lipoxygenases, and cytochromes P450. The primary metabolites from these pathways are subject to a further cascade of transformations resulting in a rich spectrum of biological active products. Recent studies have identified three principal sources of structural diversity and, hence, new eicosanoids: (a) multiple cytochrome P450 isoenzymes; (b) secondary metabolic routes includes transformation by beta-, omega-, and keto-oxidases; reductases; conjugation to taurine, glutathione, glucuronic acid, and other small molecular weight compounds; and dual pathway or transcellular oxidation; and (c) unregulated free radical processes associated with aging and/or pathophysiology that generate isoeicosanoids. The many urgent questions concerning the structure, origin, regulation, quantitation, and disposition of these eicosanoids will be addressed by (a) the isolation and structure elucidation of new eicosanoids; (b) the creation of efficient synthetic methodology and its application in unambiguous total syntheses of novel eicosanoids; (c) the preparation of selective metabolism inhibitors and eicosanoid analogs with modified activity and/or stability; (d) the development of immunoassays and instrumental assays for the detection and quantitation of eicosanoids, receptors, etc.; and (e) elucidation of the P450 active site.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM031278-15
Application #
2734461
Study Section
Special Emphasis Panel (ZRG3-BNP (02))
Project Start
1983-12-01
Project End
2000-06-30
Budget Start
1998-07-01
Budget End
1999-06-30
Support Year
15
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Genetics
Type
Schools of Medicine
DUNS #
City
Dallas
State
TX
Country
United States
Zip Code
75390
Siangjong, L; Goldman, D H; Kriska, T et al. (2017) Vascular hepoxilin and trioxilins mediate vasorelaxation through TP receptor inhibition in mouse arteries. Acta Physiol (Oxf) 219:188-201
Garcia, Victor; Shkolnik, Brian; Milhau, Laura et al. (2016) 20-HETE Activates the Transcription of Angiotensin-Converting Enzyme via Nuclear Factor-?B Translocation and Promoter Binding. J Pharmacol Exp Ther 356:525-33
Garcia, Victor; Cheng, Jennifer; Weidenhammer, Adam et al. (2015) Androgen-induced hypertension in angiotensinogen deficient mice: role of 20-HETE and EETS. Prostaglandins Other Lipid Mediat 116-117:124-30
Sato, Yuka; Sato, Waichi; Maruyama, Shoichi et al. (2015) Midkine Regulates BP through Cytochrome P450-Derived Eicosanoids. J Am Soc Nephrol 26:1806-15
Ding, Yindi; Frömel, Timo; Popp, Rüdiger et al. (2014) The biological actions of 11,12-epoxyeicosatrienoic acid in endothelial cells are specific to the R/S-enantiomer and require the G(s) protein. J Pharmacol Exp Ther 350:14-21
Hye Khan, Md Abdul; Pavlov, Tengis S; Christain, Sarah V et al. (2014) Epoxyeicosatrienoic acid analogue lowers blood pressure through vasodilation and sodium channel inhibition. Clin Sci (Lond) 127:463-74
Wang, Rui; Falck, John Russell (2014) Transformations of X (C, O, N)-CN Bonds: Cases of Selective X (C, O, N)-C Activation. RSC Adv 4:1062-1066
Li, Jing; Stier, Charles T; Chander, Praveen N et al. (2014) Pharmacological manipulation of arachidonic acid-epoxygenase results in divergent effects on renal damage. Front Pharmacol 5:187
Wang, Rui; Falck, John R (2014) Transition Metals Catalyzed Element-Cyano Bonds Activations. Catal Rev Sci Eng 56:288-331
Khan, Abdul Hye; Falck, John R; Manthati, Vijaya L et al. (2014) Epoxyeicosatrienoic acid analog attenuates angiotensin II hypertension and kidney injury. Front Pharmacol 5:216

Showing the most recent 10 out of 362 publications